These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38731442)

  • 1. Synthesis, In Vivo Anticonvulsant Activity Evaluation and In Silico Studies of Some Quinazolin-4(3H)-One Derivatives.
    Pele R; Marc G; Mogoșan C; Apan A; Ionuț I; Tiperciuc B; Moldovan C; Araniciu C; Oniga I; Pîrnău A; Vlase L; Oniga O
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity.
    Jain N; Jaiswal J; Pathak A; Singour PK
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):63-73. PubMed ID: 28056730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vivo and in silico evaluation of novel 2,3-dihydroquinazolin-4(1H)-one derivatives as potential anticonvulsant agents.
    Kothayer H; Ibrahim SM; Soltan MK; Rezq S; Mahmoud SS
    Drug Dev Res; 2019 May; 80(3):343-352. PubMed ID: 30565722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations.
    Shafie A; Mohammadi-Khanaposhtani M; Asadi M; Rahimi N; Ranjbar PR; Ghasemi JB; Larijani B; Mahdavi M; Shafaroodi H; Dehpour AR
    Mol Divers; 2020 Feb; 24(1):179-189. PubMed ID: 30895449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel spiro[indene-1,2'-quinazolin]-4'(3'H)-one derivatives as potent anticonvulsant agents: One-pot synthesis, in vivo biological evaluation, and molecular docking studies.
    Mohammadi AA; Taheri S; Shisheboran S; Ahdenov R; Mohammadi-Khanaposhtani M; Darjani PS; Masihi PH; Shakiba A; Larijani B; Mahdavi M; Ahangar N
    J Biochem Mol Toxicol; 2023 Jan; 37(1):e23234. PubMed ID: 36184906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Pharmacological Evaluation of New 3,4-Dihydroisoquinolin Derivatives Containing Heterocycle as Potential Anticonvulsant Agents.
    Zhang HJ; Shen QK; Jin CM; Quan ZS
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27916842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents.
    Mohammadi-Khanaposhtani M; Shabani M; Faizi M; Aghaei I; Jahani R; Sharafi Z; Shamsaei Zafarghandi N; Mahdavi M; Akbarzadeh T; Emami S; Shafiee A; Foroumadi A
    Eur J Med Chem; 2016 Apr; 112():91-98. PubMed ID: 26890115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives.
    Abuelizz HA; Dib RE; Marzouk M; Anouar EH; A Maklad Y; N Attia H; Al-Salahi R
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28665338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Neurotropic Activity of New Heterocyclic Systems: Pyridofuro[3,2-
    Sirakanyan SN; Spinelli D; Geronikaki A; Kartsev V; Hakobyan EK; Petrou A; Paronikyan RG; Nazaryan IM; Akopyan HH; Hovakimyan AA
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34205930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of thiopyrano[2,3-d]thiazole derivatives as potential anticonvulsant agents.
    Davydov E; Hoidyk M; Shtrygol' S; Karkhut A; Polovkovych S; Klyuchivska O; Karpenko O; Lesyk R; Holota S
    Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400357. PubMed ID: 38943436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, anticonvulsant activity and molecular modeling study of some new hydrazinecarbothioamide, benzenesulfonohydrazide, and phenacylacetohydrazide analogues of 4(3H)-quinazolinone.
    Al-Salem HS; Hegazy GH; El-Taher KE; El-Messery SM; Al-Obaid AM; El-Subbagh HI
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1490-9. PubMed ID: 25754489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and pharmacological evaluation of novel 1,2,4-triazol-3-amine derivatives as potential agonists of GABA
    Jahani R; Reza Abtahi S; Nematpour M; Fasihi Dastjerdi H; Chamanara M; Hami Z; Paknejad B
    Bioorg Chem; 2020 Nov; 104():104212. PubMed ID: 32916390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, in vivo, and in silico evaluation of new coumarin-1,2,4-oxadiazole hybrids as anticonvulsant agents.
    Mohammadi-Khanaposhtani M; Ahangar N; Sobhani S; Masihi PH; Shakiba A; Saeedi M; Akbarzadeh T
    Bioorg Chem; 2019 Aug; 89():102989. PubMed ID: 31158578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one and Its Derivatives.
    Zhang HJ; Jin P; Wang SB; Li FN; Guan LP; Quan ZS
    Arch Pharm (Weinheim); 2015 Aug; 348(8):564-74. PubMed ID: 26053879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of some 3-substituted-2-[(2,4-dichlorophenoxy)-methyl]quinazolin-4(3H)-one derivatives as potential anticonvulsant agents.
    Abbas Sel-S; Awadallah FM; Ibrahim NA; Said EG; Kamel G
    Chem Pharm Bull (Tokyo); 2013; 61(7):679-87. PubMed ID: 23812393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of anticonvulsant activities of benzoxazole derivatives containing the 1,2,4-triazolone moiety.
    Song MX; Huang Y; Wang S; Wang ZT; Deng XQ
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1800313. PubMed ID: 31330092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.
    Ugale VG; Bari SB
    Arch Pharm (Weinheim); 2016 Nov; 349(11):864-880. PubMed ID: 27680868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents.
    Khan AA; Siddiqui N; Akhtar MJ; Ali Z; Yar MS
    Arch Pharm (Weinheim); 2016 Apr; 349(4):277-92. PubMed ID: 26996080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, in vivo and in silico evaluation of phenacyl triazole hydrazones as new anticonvulsant agents.
    Dehestani L; Ahangar N; Hashemi SM; Irannejad H; Honarchian Masihi P; Shakiba A; Emami S
    Bioorg Chem; 2018 Aug; 78():119-129. PubMed ID: 29550532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.